Stock HEPA HEPION PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Hepion Pharmaceuticals, Inc.

Equities

HEPA

US4268973025

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
1.14 USD -2.56% Intraday chart for Hepion Pharmaceuticals, Inc. -8.06% -64.81%
May. 21 Hepion Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 22 Sector Update: Health Care Stocks Increase Late Afternoon MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hepion Pharmaceuticals, Inc. Appoints Michael Purcell to Its Board of Directors
CI
Hepion Pharmaceuticals, Inc. Announces Board Changes
CI
Hepion Pharmaceuticals, Inc. Announces Resignation of Anand Reddi from the Board of Directors
CI
Hepion Pharmaceuticals Approves Restructuring Plan to Preserve Capital, Launches Strategic Review Process
MT
Hepion Pharmaceuticals, Inc. Announces Resignation of Robert Foster as Director
CI
Hepion Pharmaceuticals, Inc. Announces CEO Changes
CI
Aurinia Pharmaceuticals Appoints Robert Foster as Part of Deal With Shareholder MKT Capital
MT
Hepion Pharmaceuticals, Inc. Announces Resignation of Dr. Todd Hobbs, as the Chief Medical Officer, Effective September 29, 2023
CI
Hepion Pharmaceuticals, Inc. Announces Board Appointments
CI
Hepion Pharmaceuticals, Inc. Announces Board Changes
CI
Hepion Pharmaceuticals Names Launa Aspeslet as Chief Operating Officer
MT
Hepion Pharmaceuticals, Inc. Appoints Dr. Launa J. Aspeslet as Chief Operating Officer
CI
Hepion Pharmaceuticals Appoints Eddie C. Cheung to Lead the Company’s Strategic Medical Affairs in Asia
CI
Hepion Pharmaceuticals, Inc Announces Demise of Thomas Adams, Ph.D., Member of Its Board of Directors
CI
Todd M. Hobbs, Joins Hepion Pharmaceuticals as Chief Medical Officer
CI
Hepion Pharmaceuticals, Inc. Announces Dr. Peter Wijngaard Has Joined Its Board of Directors
CI
Stephen Harrison Joins Hepion Pharmaceuticals as Consultant Medical Director
CI
Hepion Pharmaceuticals, Inc. Announces Executive Promotions
CI
Hepion Pharmaceuticals, Inc. Appoints Stephen Harrison to its Scientific Advisory Board
CI
ContraVir Pharmaceuticals, Inc. will Change its Name to Hepion Pharmaceuticals, Inc
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HEPA Stock
  4. News Hepion Pharmaceuticals, Inc.
  5. Insiders